3rd New Horizons in Immunotherapy for Head and Neck Cancer
June 15-16, 2018
3rd New Horizons in Immunotherapy for Head and Neck Cancer
Friday, June 15 and Saturday, June 16
Renaissance Pittsburgh Hotel
107 6th Street
Pittsburgh, PA 15222
Program Goal
To increase the health care provider’s knowledge of available immunotherapy agents and the rationale for ongoing and future clinical trials.
Who Should Attend
This conference is designed for leaders in head and neck cancer who are interested in immunotherapy advancements for the treatment of cancer patients.
Course Directors
Robert Ferris, MD, PhD
UPMC Hillman Cancer Center, University of Pittsburgh School of Medicine
R. Bryan Bell, MD, DDS, FACS
Earle A. Chiles Research Institute at Robert W. Franz Cancer Center, Providence Cancer Institute
Ezra Cohen, MD, FRCPSC, FASCO
UC San Diego, San Diego Center for Precision Immunotherapy, Moores Cancer Center
For more information, contact Mary Kate Ayers at eganmk@upmc.edu or 412-623-3651.
Course brochure with detailed information is available at https://ccehs.upmc.com/courses/brochure_6606.pdf
The University of Pittsburgh School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
The University of Pittsburgh School of Medicine designates this live activity for a maximum of 13.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Other health care professionals are awarded 1.3 continuing education units (CEU’s) which are equal to 13.2 contact hours.
The University of Pittsburgh is an affirmative action, equal opportunity institution.
